Legionella Testing Market Size, Share & Trends Analysis Report By Test Type (Culture, Urine Antigen Test (UAT), Direct Fluorescent Antibody (DFA) Test), By End-Use (Hospitals & Clinics, Diagnostics Laboratories, Water Treatment Industries), By Region, And By Segment Forecasts, 2023-2031

The Legionella Testing Market Size is valued at USD 295.21 Mn in 2022 and is predicted to reach USD 551.37 Mn by the year 2031 at a 7.3% CAGR during the forecast period for 2023-2031.

Legionella testing detects the presence of the bacterium Legionella pneumophila and other related species in water sources. The testing procedure is critical for identifying potential Legionella contamination sources and averting Legionnaires' disease outbreaks. Legionella testing procedures have become more efficient and accurate as testing technology has advanced.

PCR-based testing and next-generation sequencing (NGS) are two technologies that have gained popularity as a result of their shorter turnaround times and ability to deliver more detailed information. The technologies that power molecular diagnostics are fast improving to aid in the fight against rapidly spreading infectious disease pandemics. The traditional Legionella testing method based on microbial culture technology is time-consuming and labor-intensive.

However, certain industries, such as hospitality and tourism, were significantly affected by the pandemic, leading to reduced occupancy or temporary closures of hotels, resorts, and other facilities. These changes could have influenced the demand for Legionella testing in these sectors. 

Competitive Landscape:

Some major key players in the Legionella Testing Market:

• Thermo Fisher Scienific, Inc. (US)
• Merck KGaA (Germany)
• Becton, Dickinson, and Company (US)
• Roche Diagnostics (Switzerland)
• Pall Corporation (US)
• Pro-lab Diagnostics Inc.
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Alere Inc. (Abbott Rapid Diagnostics)
• Eiken Chemical Co. Ltd.
• Hologic Inc.
• QIAGEN
• Takara Bio Inc.
• Environmental Safety Technologies Inc.
• Hydrosense
• Accepta Ltd.
• LuminUltra Technologies Ltd.
• Pro-Lab Diagnostics Inc.
• BioAlert Solutions
• Pacific Water Technology
• Aquacert Ltd.
• DTK Water
• Sens Solutions
• Genomadix Inc.
• Phigenics LLC

Market Segmentation: 

The Legionella Testing Market is segmented on the basis of test type and end-use. Acording to test type, the market is segmented as culture, Urine Antigen Test (UAT), and Direct Fluorescent Antibody (DFA) Test. The end-user segment includes hospitals & clinics, diagnostics laboratories, and water treatment industries. 

Based On Test Type, The Urine Antigen Test (UAT)Segment Is Accounted As A Major Contributor In The Legionella Testing Market 

The Urine Antigen Test (UAT) category is expected to hold a major share of the global Legionella Testing Market in 2022. This is the most widely used laboratory test for detecting legionella bacteria in urine. It can offer results on the same day as the sample collection, as opposed to culture media approaches, which take 7 to 8 days. Furthermore, it is a low-cost test that is more popular among people from underdeveloped or developing countries. Rapidly rising PCR technology to dominate the market with a higher CAGR over the forecast period due to the maximum selectivity and specificity of the test. 

The Diagnostics Laboratories Segment Witnessed Growth At A Rapid Rate 

The diagnostics laboratories segment is projected to grow at a rapid rate in the global Legionella Testing Market. This is due to the increasing prevalence of Legionnaire disease, more awareness, and increased penetration of improved assays for Legionella infection detection. This dominance is expected to persist throughout the projection period. The other segment, which encompasses environmental testing in addition to clinical Legionella bacteria testing, is expected to grow rapidly due to the advent of onsite testing methodologies and the enforcement of rigorous rules for routine water check-ups. 

In The Region, The North America Legionella Testing Market Holds A Significant Revenue Share 

The North America Legionella Testing Market is expected to register the topmost market share in terms of revenue in the near future. The market in this region is distinguished by high Legionnaire disease diagnostic rates, the presence of world-class healthcare infrastructure, high illness awareness, and severe water testing requirements.

The presence of a large geriatric population that is readily infected, together with the high risk of mortality owing to associated pneumonia among such patients, prioritizes Legionella testing in countries such as the United States, which is adding momentum to the regional market. The Asia-Pacific market is expected to grow at a substantial CAGR within the forecast period due to economic development, an empowered healthcare industry, and increased awareness of available test products in the region. 

Legionella Testing Market Report Scope: